PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Europe

Alzheimer’s disease: amyloid β protein once again in the spotlight as a therapeutic target

World Alzheimer's Day on 21 September 2018 (Vienna, 18 September 2018) For many years amyloid β protein was considered to be a promising therapeutic target in Alz...
Continue Reading →
Europe

Persons with Alzheimer’s disease are more often hospitalized after initiating antibiotic use

Persons with Alzheimer’s disease (AD) are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finla...
Continue Reading →
Asia Pacific

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer

C201 phase 2 will study immuno-enhancer antibody GM102, targeting AMHRII as a single agent and in combination with Trifluridine/Tipiracil (Lonsurf®) Paris and Toulou...
Continue Reading →
Europe

Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Atezolizumab in Bladder Cancer

Bavarian Nordic-sponsored study has commenced dosing Study marks the second of three planned Phase 2 combination studies of CV301 with checkpoint inhibitors in s...
Continue Reading →
Europe

Celtaxsys Announces Results of Phase 2 Trial Showing Clinically Meaningful Improvement in Pulmonary Exacerbations in Cystic Fibrosis Patients

Celtaxsys, Inc., a clinical stage pharmaceutical development company focused on advancing treatments for patients with rare inflammatory diseases, announced top line ...
Continue Reading →
news

New malaria drug starts clinical trials

Release of malaria parasites from red blood cell. After decades a new drug against malaria has been develope...
Continue Reading →
news

Johns Hopkins scientists successfully perform 3D personalized virtual simulations of the heart

In a proof of concept study, scientists at Johns Hopkins report they have successfully performed 3D personalized virtual simulations of the heart to accurately identi...
Continue Reading →
Europe

Study links widely-used drug azathioprine to skin cancers

A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an impor...
Continue Reading →
Europe

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

Study Seeks to Confirm Efficacy and Safety of Next-generation Clot-dissolving Therapy Consisting of Low-dose tPA and HisproUK. Cambridge, Mass., USA, September 05, 20...
Continue Reading →
Europe

RSP Systems Adds EUR 3,85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10,35 Million

Odense, Denmark, September 10, 2018 / B3C newswire / -- RSP Systems A/S, the non-invasive diagnostics company, announces that it has completed second closing of its S...
Continue Reading →
Quotient